Remove Hurdles to Cancer Care

Share

COVID-19 has shone a spotlight on the significant barriers to affordable health care that cancer patients have long faced. While relief packages and proposals to date have worked to address affordability of COVID-specific testing and treatment, policymakers must also tackle hurdles that cancer patients face like removing the red tape of prior authorization and step therapy, reducing out-of-pocket costs, and ensuring cost-sharing assistance directly benefits patients. There has been a great deal of research and investment in effective therapies that allow people fighting cancer to survive and live longer. Cancer patients need Congress to act quickly to remove hurdles to quality care.

56% of cancer patients and survivors are worried about being able to afford their treatment

Latest Updates

March 25, 2021
Michigan

LANSING, MI – The American Cancer Society Cancer Action Network (ACS CAN) is thrilled to see the House pass oral chemotherapy fairness legislation today. ACS CAN wants to take this moment to thank Rep. Daire Rendon for supporting and sponsoring this legislation. It has never been more critical for people

January 8, 2021
Illinois

SPRINGFIELD, IL – As lawmakers dive into the new year, the American Cancer Society Cancer Action Network (ACS CAN) asks that legislators support legislation that will ease the cancer burden in Illinois. Long after this pandemic passes, people deserve to live full, healthy lives. ACS CAN is advocating for: Prescription

December 18, 2020
National

The U.S. Senate passed legislation tonight aimed at improving access to clinical trials for communities of color and decreasing health disparities.

Cancer Candor Blog
October 22, 2020

The true costs of cancer are heavy, they are deep, and they are ultimately unaffordable for many, a challenge further exacerbated by this year’s COVID-19 pandemic and spotlighted by the upcoming Supreme Court case challenging the Affordable Care Act.

Remove Hurdles to Cancer Care Resources

The U.S. spent approximately $183 billion on cancer-related health care in 2015. This represents a signification portion of the total health care spending in the U.S. And it is expected to keep growing. By 2030 cancer-related health care spending is expected to reach nearly $246 billion.

Many cancer patients take multiple drugs as part of their treatment – often for many months or years. While drugs are not the only costly part of cancer treatment, finding ways to reduce these costs for patients and payers will significantly reduce the overall cost burden of cancer.

Many cancer patients have difficulty affording the cost of their prescription drugs, regardless of whether they are insured.  This is especially true for newer drugs that do not have a generic equivalent.  Many programs exist to help patients afford their medication.  This fact sheet focuses on two of these – patient assistance programs and discount coupons.